Clinical trial

Effect of Blueberry Supplementation on Alzheimer's Biomarkers

NCT05172128

Study summary

ClinicalTrials.gov

Effect of Blueberry Supplementation on Alzheimer's Biomarkers

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIETARY_SUPPLEMENT · Unmapped registry intervention lyophilized blueberry supplement Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-02-21

PhaseNA

Conditions

Mild Cognitive Impairmentunresolved

Alzheimer Diseaseverified · MONDO: Alzheimer disease

Interventions

lyophilized blueberry supplementDIETARY_SUPPLEMENT

Sponsors & collaborators

Duke Universitylead sponsor

U.S. Highbush Blueberry Councilcollaborator

Mapped research locations

DurhamNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05172128 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.